July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Normalization of Visual Evoked Potential with Treatment of Selective Trabeculoplasty Laser
Author Affiliations & Notes
  • Yianni Yiannakou
    Ophthalmology, South Bay Retina, Sunnyvale, California, United States
  • Lynnette Hoai Nguyen
    Ophthalmology, South Bay Retina, Sunnyvale, California, United States
  • Paul Namkoong
    Ophthalmology, South Bay Retina, Sunnyvale, California, United States
  • Keshav Narain
    Ophthalmology, South Bay Retina, Sunnyvale, California, United States
  • Footnotes
    Commercial Relationships   Yianni Yiannakou, None; Lynnette Nguyen, None; Paul Namkoong, None; Keshav Narain, None
  • Footnotes
    Support  none.
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 6093. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yianni Yiannakou, Lynnette Hoai Nguyen, Paul Namkoong, Keshav Narain; Normalization of Visual Evoked Potential with Treatment of Selective Trabeculoplasty Laser. Invest. Ophthalmol. Vis. Sci. 2018;59(9):6093.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Visual evoked potentials (VEPs) are used to measure the integrity of the visual pathways from the retina via the optic nerves to the occipital cortex. In clinical practice, the prolongation of high contrast VEP latency allows an objective measure of early glaucomatous progression before subjective visual field loss occurs1. We performed a retrospective, observational clinical analysis to determine if treatment with 360-degree Selective Laser Trabeculoplasty (SLT) can stabilize glaucomatous progression in patients by normalizing optic nerve high contrast latencies, per VEPs.

Methods : We analyzed 121 eyes of 80 patients with open-angle-glaucoma (OAG) who received 360-degree SLT treatment following prolonged high contrast latency per VEP, over the course of 3 years. The laser was applied to the patient’s trabecular meshwork (TM) of the affected eye(s) at various power levels of 0.6 -1.2mJ with respect to patient’s TM pigmentation. Patients were reevaluated 6 months status-post SLT with repeat VEP to determine response of high contrast latency in the treated eye(s). South Bay Retina, Inc. Ophthalmology Clinic permitted use of anonymous clinical data.

Results : Of the 121 eyes treated, 62% (75 eyes) experienced a normalization of VEP at least 6 months status-post SLT treatment, while 38% (46 eyes) did not.


Conclusions : VEP is a valuable objective measure for early-diagnosis and prognosis of OAG. We believe that normalization of high contrast VEP latency is an early indicator of optic nerve response to therapy. With SLT treatment, such progression of OAG-induced, early optic nerve dysfunction may be reversible before visual field loss occurs. Future studies may further investigate SLT as an effective replacement therapy in lieu of topical IOP lowering medications with an added benefit of reversing early glaucomatous changes.

1 Ruchi Kothari, Pradeep Bokariya, Smita Singh, and Ramji Singh, “Significance of Visual Evoked Potentials in the Assessment of Visual Field Defects in Primary Open-Angle Glaucoma: A Review,” Neuroscience Journal, vol. 2013, Article ID 418320, 6 pages, 2013. doi:10.1155/2013/418320

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×